EUVIMEDEUVIMED entdecken
Crossref

RESISTENCIA A LA INSULINA EN LA DIABETES MELLITUS TIPO 2 Y SU PAPEL EN LA PROGRESIÓN DE LA ENFERMEDAD RENAL CRÓNICA Y LAS COMPLICACIONES CARDIOVASCULARES: UNA REVISIÓN NARRATIVA CRÍTICA CON BÚSQUEDA ESTRUCTURADA

Telmo Eduardo Salas Joya, Leonardo Lanzee Mendoza Jiménez, Evelyn Ileana Reyes Yagual, Patricia Lorena Peralvo Bustos

VitalyScience Revista Científica Multidisciplinaria · 2026

DOI: 10.56519/71yk8030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift VitalyScience Revista Científica Multidisciplinaria, 2026. Verfasst von Telmo Eduardo Salas Joya und 3 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes is a global health problem whose complications—such as kidney and heart disease—contribute significantly to morbidity and mortality. Insulin resistance is a key factor in type 2 diabetes. For a long time, this resistance was thought to affect only blood glucose control. However, recent research has begun to explore its possible role as a link between kidney and vascular damage. The aim of this review was to analyze the available evidence on how insulin resistance relates to the progression of chronic kidney disease and cardiovascular complications in adults with type 2 diabetes. A literature search was conducted in databases including PubMed, Scopus, Web of Science, ScienceDirect, and Cochrane Library, covering publications from January 2020 to August 2026. Observational studies, systematic reviews, clinical trials, and guidelines were included. The studies examined insulin resistance in relation to renal outcomes such as albuminuria, reduction in glomerular filtration rate, and end-stage renal disease, as well as its connection to cardiovascular outcomes including major adverse events and heart failure. The results show that insulin resistance is associated with the presence of albumin in urine and worse renal function, likely due to mechanisms such as hyperfiltration, inflammation, oxidative stress, and lipotoxicity. Furthermore, a clear connection exists between insulin resistance and atherosclerosis, arterial damage, and cardiac problems. However, there is limited direct evidence demonstrating how insulin resistance leads to the initiation of hemodialysis. Certain medications, such as SGLT2 inhibitors, GLP-1 receptor agonists, and finerenone, offer benefits beyond glycemic control. The review concludes that the evidence supports a clear and logical relationship between insulin resistance, kidney damage, and cardiovascular risk. Nevertheless, heterogeneity between studies and the predominantly observational nature of the evidence limit the ability to establish direct causal relationships.

Zitieren

APA

Joya, T. E. S., Jiménez, L. L. M., Yagual, E. I. R., & Bustos, P. L. P. (2026). RESISTENCIA A LA INSULINA EN LA DIABETES MELLITUS TIPO 2 Y SU PAPEL EN LA PROGRESIÓN DE LA ENFERMEDAD RENAL CRÓNICA Y LAS COMPLICACIONES CARDIOVASCULARES: UNA REVISIÓN NARRATIVA CRÍTICA CON BÚSQUEDA ESTRUCTURADA. VitalyScience Revista Científica Multidisciplinaria. https://doi.org/10.56519/71yk8030

Vancouver

Joya TES, Jiménez LLM, Yagual EIR, Bustos PLP. RESISTENCIA A LA INSULINA EN LA DIABETES MELLITUS TIPO 2 Y SU PAPEL EN LA PROGRESIÓN DE LA ENFERMEDAD RENAL CRÓNICA Y LAS COMPLICACIONES CARDIOVASCULARES: UNA REVISIÓN NARRATIVA CRÍTICA CON BÚSQUEDA ESTRUCTURADA. VitalyScience Revista Científica Multidisciplinaria. 2026. doi:10.56519/71yk8030

BibTeX
@article{Joya2026,
  author = {Joya, Telmo Eduardo Salas and Jiménez, Leonardo Lanzee Mendoza and Yagual, Evelyn Ileana Reyes and Bustos, Patricia Lorena Peralvo},
  title = {RESISTENCIA A LA INSULINA EN LA DIABETES MELLITUS TIPO 2 Y SU PAPEL EN LA PROGRESIÓN DE LA ENFERMEDAD RENAL CRÓNICA Y LAS COMPLICACIONES CARDIOVASCULARES: UNA REVISIÓN NARRATIVA CRÍTICA CON BÚSQUEDA ESTRUCTURADA},
  journal = {VitalyScience Revista Científica Multidisciplinaria},
  year = {2026},
  doi = {10.56519/71yk8030}
}
Kostenlos starten →